Nathan and Oski's Hematology and Oncology of Infancy and Childhood, 2-Volume Set, 8th Edition

9781455754144

By Stuart H. Orkin, MD, David G Nathan Professor of Pediatrics, Harvard Medical School; Chair, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital; Investigator, Howard Hughes Medical Institute, Boston, Massachusetts; David G. Nathan, MD, President Emeritus, Dana-Farber Cancer Institute, Physician-in-Chief Emeritus, Boston Children's Hospital; Stranahan Distinguished Professor of Pediatrics and Professor of Medicine, Harvard Medical School, Boston, Massachusetts; David Ginsburg, MD, James V Neel Distinguished University Professor, Departments of Internal Medicine, Pediatrics, and Communicable Diseases, and Human Genetics, Investigator, Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, Michigan; A. Thomas Look, MD, Professor of Pediatrics, Harvard Medical School; Vice Chair for Research, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston Children's Hospital, Boston, Massachusetts; David E. Fisher, MD, PhD, Chief, Department of Dermatology, Director, Cutaneous Biology Research Center, Massachusetts General Hospital; Director, Melanoma Program, Massachusetts General Hospital Cancer Center, Boston, Massachusetts; Samuel Lux, MD, Robert A Stranahan Professor of Pediatrics, Harvard Medical School and Chief Emeritus, Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts

2015

8

Section I Neonatal Hematology

1. Anatomy and Physiology of Hematopoiesis

2. The Neonatal Erythrocyte and Its Disorders

3. Immune Hemolytic Disease

4. Neonatal Jaundice and Disorders of Bilirubin Metabolism

5. Hemostasis in the Newborn and Infant

Section II Bone Marrow Failure

6. Acquired Aplastic Anemia and Pure Red Cell Aplasia

7. Inherited Bone Marrow Failure Syndromes

8. Principles of Bone Marrow and Stem Cell Transplantation

Section III Disorders of Erythrocyte Production

9. Diagnostic Approach to the Anemic Patient

10. Megaloblastic Anemia

11. Disorders of Iron and Copper Metabolism, Sideroblastic Anemias and Lead Toxicity

12. Porphyrias

Section IV Hemolytic Anemias

13. Autoimmune Hemolytic Anemia

14. Paroxysmal Nocturnal Hemoglobinuria

15. Red Cell Membrane

16. Disorders of the Red Cell Membrane

17. Pyruvate Kinase Deficiency and Disorders of Glycolysis

18. Glucose-6-Phosphate Dehydrogenase Deficiency

19. Normal and Abnormal Hemoglobins

Section V Disorders of Hemoglobin

20. Sickle Cell Disease

21. Thalassemias

Section VI Phagocyte System

22. Phagocyte System and Disorders of Granulopoiesis and Granulocyte Function

Section VII Immune System

23. Immune Response

24. Primary Immunodeficiency Diseases

Section VIII Storage Diseases

25. Lysosomal Storage Diseases

Section IX Hemostasis

26. Platelets and the Vessel Wall

27. Blood Coagulation

28. Molecular Basis of Fibrinolysis

29. Approach to the Child with a Suspected Bleeding Disorder

30. Inherited Platelet Disorders

31. Hemophilia and von Willebrand Disease

32. Rare Hereditary Coagulation Factor Abnormalities

33. Inherited Disorders of Thrombosis and Fibrinolysis

34. Acquired Platelet Defects

35. Acquired Disorders of Hemostasis

Section X Supportive Therapy

36. Transfusion Medicine

Section XI Hematologic Manifestations of Systemic Diseases

37. Hematological Manifestations of Systemic Diseases

38. Hematology Manifestations of Systemic Diseases in Children of the Developing World

Section XII Biology of Cancer

39. Origins and Evolution of Pediatric Cancer

40. Epidemiology of Leukemia in Childhood

41. Informatics

42. Genetic Predisposition to Cancer

43. Genetic and Epigenetics of Childhood Cancers

44. Targeted Therapies in Oncology

45. Cytogenetic and Molecular Pathology of Pediatric Cancer

Section XIII Pediatric Cancer Therapeutics

46. Cancer Chemotherapy for Pediatric Patients

47. Immunotherapy of Cancer

48. Pediatric Radiation Oncology

48. Pediatric Surgical Oncology

Section XIV Hematologic Malignancy

50. Acute Lymphoblastic Leukemia

51. Pediatric Myeloid Leukemia, Myelodysplasia, and Myeloproliferative Disease

52. Infant Leukemias

53. Pediatric Lymphoma

Section XV Solid Tumors

54. Neuroblastoma

55. Pediatric Renal Tumors

56. Retinoblastoma

57. Tumors of the Brain and Spinal Cord

58. Hepatoblastoma and Other Liver Tumors in Children

59. Rhabdomyosarcoma

60. Nonrhabdomyosarcoma Soft Tissue Sarcomas and Other Soft Tissue Tumors

61. Ewing Sarcoma

62. Osteosarcoma

63. Pediatric Germ Cell Tumors

64. Histiocytoses

65. Rare Tumors of Childhood

66. Imaging in the Evaluation and Management of Childhood Cancer

Section XVI Supportive Care

67. Infectious Disease in the Pediatric Cancer Patient

68. Oncologic Emergencies

69. Nursing Care of Patients with Childhood Cancer

70. Palliative Care in Pediatric Oncology

71. Symptom Management in Children with Cancer

72. Childhood Cancer Survivorship

73. Psychosocial Care of the Child and Family

74. Ethical Considerations in Pediatric Oncology Clinical Trials

Appendices: Reference Values in Infancy and Childhood

342 MB